Insulet stock heads into the open after a 0.1 percent rise
Published on 09/25/2026 at 08:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Insulet stock closed at USD 135.16 on the Nasdaq on September 24, 2026, up 0.1 percent. The shares traded near their 52-week low of USD 126.40, while the Nasdaq Composite rose 0.01 percent to 26,939.37 on the same session.
September 24, 2026 in numbers
Insulet Corporation (ISIN US45784P1012, Nasdaq: PODD) finished the session at USD 135.16, according to market data reported for September 24, 2026. The close was USD 8.76, or 6.9 percent, above the reported 52-week low of USD 126.40.
As Investing.com reported on September 24, 2026, Insulet presented at the Bernstein Insights healthcare forum, where management discussed growth, customer retention and its automated insulin delivery strategy. The report also placed the shares near the 52-week low and said they were down 52 percent year to date.
September 25, 2026 outlook
The Bernstein healthcare forum remains the latest company-specific event entering the September 25, 2026 session. The broader Nasdaq Composite closed at 26,939.37, up 0.01 percent on September 24, 2026, providing a quantified market comparison for the stock.
